4 CROI Briefs

Another year of the Conference on Retroviruses and Opportunistic Infections (CROI 2016) has come to pass. Here are a few less publicized but important...

Interferon & HIV

Luis J. Montaner DVM, D.Phil, of the Wistar Institute in Philadelphia, Pennsylvania has been studying the effects of interferon on HIV DNA and its...

AR-12: One Drug Candidate, Many Possibilities

One Drug, Many Possibilities A new agent may assist in the fight against HIV and other viruses by Jeannie Wraight Every once in a while I come...

Talking “Cure”

Nobel Prize Laureate and world renowned HIV researcher Françoise Barré-Sinoussi recently made the statement that she does not believe an HIV cure is possible....

Eye on the Future

Towards an HIV Cure is an initiative of the International AIDS Society (IAS) formed to help direct and facilitate discussion, research and policy to...

Expediting Research

GlaxoSmithKline (GSK) and the University of North Carolina at Chapel-Hill (UNC) will launch a jointly owned novel HIV Cure Center, as well as a...

Vpu Inhibitor Candidate

BIT225 is a new type of antiviral called a Vpu inhibitor, which researchers are investigating to treat both HIV and HIV/hepatitis C (HCV) co-infection....

Countdown to a Cure

by Jeannie Wraight As part of the Countdown to a Cure Initiative, amfAR (The Foundation for AIDS Research) will direct $20 million, of a $100...

Women & PrEP

LifeGuide It's a Man's World Research on women & PrEP needs to keep pace by Jeannie Wraight   Whereas HIV cure and HIV prevention are two very different...

The True End of AIDS

LifeGuide Trump Card Treatment and prevention are important, but an HIV cure will be the true end of AIDS by Jeannie Wraight Lately, we have been hearing a...